Gelonghui announced on August 28th that YAHong Pharmaceuticals (688176.SH) has released a restricted stock incentive plan for 2024. The plan plans to grant 8.3201 million restricted stocks to the incentive recipients, accounting for approximately 1.46% of the total shares of the company's capital, which was 570 million shares at the time of the announcement of the incentive plan draft. The grant is a one-time grant with no reserved portions.